相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
Andy I. Choi et al.
AIDS (2011)
Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data
Mario Cruciani et al.
AIDS (2011)
High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors
Elisabeth Aslangul et al.
AIDS (2011)
T cell activation predicts carotid artery stiffness among HIV-infected women
Robert C. Kaplan et al.
ATHEROSCLEROSIS (2011)
Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir
Sergio Padilla et al.
BMC INFECTIOUS DISEASES (2011)
Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s
Grace A. McComsey et al.
CLINICAL INFECTIOUS DISEASES (2011)
Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case-Control Study Using Quebec's Public Health Insurance Database
Madeleine Durand et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
Grace A. McComsey et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Platelet function and HIV: a case-control study
Claudette S. Satchell et al.
AIDS (2010)
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
Allison Martin et al.
AIDS (2010)
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction
Esteban Martinez et al.
AIDS (2010)
Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study
Frank J. Palella et al.
AIDS (2010)
Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus-Infected Patients A Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4
Sylvie Lang et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children
Allison C. Ross et al.
ATHEROSCLEROSIS (2010)
Differential Effects of Efavirenz and Lopinavir/Ritonavir on Human Adipocyte Differentiation, Gene Expression and Release of Adipokines and Pro-Inflammatory Cytokines.
Jose M. Gallego-Escuredo et al.
CURRENT HIV RESEARCH (2010)
Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy
Todd T. Brown et al.
DIABETES CARE (2010)
Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study
N. Obel et al.
HIV MEDICINE (2010)
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Signe Westring Worm et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy
Allison C. Ross et al.
CLINICAL INFECTIOUS DISEASES (2009)
Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects
Cindy H. Brothers et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
Todd T. Brown et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Abacavir and Cardiovascular Risk in HIV-Infected Patients: Does T Lymphocyte Hyperactivation Exert a Pathogenic Role?
Giulia Marchetti et al.
CLINICAL INFECTIOUS DISEASES (2008)
Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels - The Fat Redistribution and Metabolic Change in HIV Infection (FRAM) study
Jason S. Reingold et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women
Sabina Cauci et al.
OBSTETRICS AND GYNECOLOGY (2008)
Body weight and oral contraceptives are the most important modulators of serum CRP levels
S. Buchbinder et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
Lewis H. Kuller et al.
PLOS MEDICINE (2008)
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses
Priscilla Y. Hsue et al.
AIDS (2006)
C-reactive protein is a marker for human immunodeficiency virus disease progression
B Lau et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen
AL Landay et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
C-reactive protein is an independent predictor of mortality in women with HIV-1 infection
JG Feldman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
分享论文
